Denzel Zhu1, William Shyr1, Michelle Toker1, Ethan Fram2, Jinrong Cheng1,3, Evan Z Kovac1,2, Ilir Agalliu2,4, Ahmed Aboumohamed1,2, Kara L Watts5,6. 1. Albert Einstein College of Medicine, Bronx, NY, USA. 2. Department of Urology, Montefiore Medical Center, Montefiore Medical Center, Albert Einstein College of Medicine, 1250 Waters Place, Tower 1; Penthouse, Bronx, NY, 10461, USA. 3. Department of Pathology, Montefiore Medical Center, Bronx, NY, USA. 4. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 5. Albert Einstein College of Medicine, Bronx, NY, USA. kwatts@montefiore.org. 6. Department of Urology, Montefiore Medical Center, Montefiore Medical Center, Albert Einstein College of Medicine, 1250 Waters Place, Tower 1; Penthouse, Bronx, NY, 10461, USA. kwatts@montefiore.org.
Abstract
OBJECTIVE: To perform a systematic review and a retrospective cohort analysis evaluating the rates of surgical downgrading of prostate cancer (PCa) from biopsy (PBx) to radical prostatectomy (RP), and their association with biochemical recurrence (BCR) in a multiethnic population. METHODS: A systematic review of PubMed and other databases was performed. We included retrospective studies evaluating the relationship between surgical downgrading and BCR-free survival. Data regarding Gleason score (GL) downgrading were abstracted from the articles and categorized as follows: GL8-10 to GL7, GL7 to GL6, and GL 7(4 + 3) to GL7(3 + 4). We also performed a retrospective cohort review of patients who underwent RP at our institution from 2005 through 2020. Kaplan-Meier survival analysis and Cox proportional hazards models were used to compare BCR among downgraded versus non-downgraded men. RESULTS: Systematic review yielded 137 abstracts; of these, 36 full-texts were reviewed, 8 of which were included in our systematic review. Despite substantial variability, all showed that GL at RP is one of the most important factors of BCR-free survival. A total of 1,484 men with PCa were analyzed from our institution. On multivariate analysis, GL7 to GL6 downgrading (HR = 0.50, p = 0.022) and GL8-10 to GL7 downgrading (HR = 0.42, p = 0.011) were associated with reduced risk of BCR when compared to men with GL7 and GL8-10 concordance, respectively. However, GL7(4 + 3) to GL7(3 + 4) downgrading was not significantly associated with reduced BCR (HR = 0.56, p = 0.12), when compared to GL7(4 + 3) concordance, although HR was similar. CONCLUSION: Surgical downgrading at RP was associated with a reduced risk of BCR compared to GL concordant disease, and these findings have been validated within our multiethnic population. Pathologic downgrading at the time of RP may be a more useful predictor of subsequent BCR in comparison to that associated with GL concordant pathology.
OBJECTIVE: To perform a systematic review and a retrospective cohort analysis evaluating the rates of surgical downgrading of prostate cancer (PCa) from biopsy (PBx) to radical prostatectomy (RP), and their association with biochemical recurrence (BCR) in a multiethnic population. METHODS: A systematic review of PubMed and other databases was performed. We included retrospective studies evaluating the relationship between surgical downgrading and BCR-free survival. Data regarding Gleason score (GL) downgrading were abstracted from the articles and categorized as follows: GL8-10 to GL7, GL7 to GL6, and GL 7(4 + 3) to GL7(3 + 4). We also performed a retrospective cohort review of patients who underwent RP at our institution from 2005 through 2020. Kaplan-Meier survival analysis and Cox proportional hazards models were used to compare BCR among downgraded versus non-downgraded men. RESULTS: Systematic review yielded 137 abstracts; of these, 36 full-texts were reviewed, 8 of which were included in our systematic review. Despite substantial variability, all showed that GL at RP is one of the most important factors of BCR-free survival. A total of 1,484 men with PCa were analyzed from our institution. On multivariate analysis, GL7 to GL6 downgrading (HR = 0.50, p = 0.022) and GL8-10 to GL7 downgrading (HR = 0.42, p = 0.011) were associated with reduced risk of BCR when compared to men with GL7 and GL8-10 concordance, respectively. However, GL7(4 + 3) to GL7(3 + 4) downgrading was not significantly associated with reduced BCR (HR = 0.56, p = 0.12), when compared to GL7(4 + 3) concordance, although HR was similar. CONCLUSION: Surgical downgrading at RP was associated with a reduced risk of BCR compared to GL concordant disease, and these findings have been validated within our multiethnic population. Pathologic downgrading at the time of RP may be a more useful predictor of subsequent BCR in comparison to that associated with GL concordant pathology.
Authors: Mark L Gonzalgo; Patrick J Bastian; Leslie A Mangold; Bruce J Trock; Jonathan I Epstein; Patrick C Walsh; Alan W Partin Journal: Urology Date: 2006-01 Impact factor: 2.649
Authors: Won Sik Jang; Dong Hoon Koh; Jongchan Kim; Jong Soo Lee; Doo Yong Chung; Won Sik Ham; Koon Ho Rha; Young Deuk Choi Journal: Prostate Date: 2019-09-04 Impact factor: 4.104
Authors: Farzana A Faisal; Debasish Sundi; John L Cooper; Elizabeth B Humphreys; Alan W Partin; Misop Han; Ashley E Ross; Edward M Schaeffer Journal: Urology Date: 2014-12 Impact factor: 2.649
Authors: Michael Müntener; Jonathan I Epstein; David J Hernandez; Mark L Gonzalgo; Leslie Mangold; Elizabeth Humphreys; Patrick C Walsh; Alan W Partin; Matthew E Nielsen Journal: Eur Urol Date: 2007-11-20 Impact factor: 20.096
Authors: Michael S Cohen; Robert S Hanley; Teodora Kurteva; Robin Ruthazer; Mark L Silverman; Andrea Sorcini; Karim Hamawy; Robert A Roth; Ingolf Tuerk; John A Libertino Journal: Eur Urol Date: 2008-03-28 Impact factor: 20.096
Authors: Muammer Altok; Patricia Troncoso; Mary F Achim; Surena F Matin; Graciela N Gonzalez; John W Davis Journal: Asian J Androl Date: 2019 Nov-Dec Impact factor: 3.285
Authors: Helen Y Hougen; Oleksii A Iakymenko; Sanoj Punnen; Chad R Ritch; Bruno Nahar; Dipen J Parekh; Oleksandr N Kryvenko; Mark L Gonzalgo Journal: World J Urol Date: 2022-06-10 Impact factor: 3.661